167 related articles for article (PubMed ID: 30550505)
1. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
Wang J; Cao B
Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use.
Chan HP; Lim TK
Curr Opin Pulm Med; 2019 Mar; 25(2):150-157. PubMed ID: 30418243
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
4. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
[No Abstract] [Full Text] [Related]
5. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
[TBL] [Abstract][Full Text] [Related]
6. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.
Li Z; Yuan X; Yu L; Wang B; Gao F; Ma J
Medicine (Baltimore); 2019 Aug; 98(32):e16775. PubMed ID: 31393400
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.
Huang L; Wang J; Gu X; Sheng W; Wang Y; Cao B
BMJ Open; 2021 Aug; 11(8):e049515. PubMed ID: 34353802
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-guided antibiotic therapy in AECOPD patients: Overview of systematic reviews.
Di J; Li X; Xie Y; Yang S; Yu X
Clin Respir J; 2021 Jun; 15(6):579-594. PubMed ID: 33683808
[TBL] [Abstract][Full Text] [Related]
11. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
[TBL] [Abstract][Full Text] [Related]
13. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
Pandey S; Garg R; Kant S; Verma A; Gaur P
Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
[TBL] [Abstract][Full Text] [Related]
14. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
Tokman S; Schuetz P; Bent S
Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Qian W; Huang GZ
Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin to guide antibiotic decision making.
Branche A; Neeser O; Mueller B; Schuetz P
Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
[TBL] [Abstract][Full Text] [Related]
18. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K
Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234
[TBL] [Abstract][Full Text] [Related]
19. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
